Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition. | J Exp Clin Cancer Res | 2022 | 35292107 | PubTator, text mining | PubMed |
| Cleavage-defective Topoisomerase I mutants sharply increase G-quadruplex-associated genomic instability. | Microb Cell | 2022 | 35291312 | PubTator, text mining | PubMed |
| Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer. | Sci Rep | 2022 | 35288618 | PubTator, text mining | PubMed |
| Ribonucleotide Incorporation by Eukaryotic B-Family Replicases and Its Implications for Genome Stability. | Annu Rev Biochem | 2022 | 35287470 | PubTator, text mining | PubMed |
| Characterization of non-small cell lung cancer transforming to small cell lung cancer and its response to EGFR-TKI: a case report. | Ann Transl Med | 2022 | 35282065 | PubTator, text mining | PubMed |
| A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas. | Front Oncol | 2022 | 35280788 | PubTator, text mining | PubMed |
| Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities. | Neurooncol Adv | 2022 | 35274102 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| DTS-Depth: Real-Time Single-Image Depth Estimation Using Depth-to-Space Image Construction. | Sensors (Basel) | 2022 | 35271061 | PubTator, text mining | PubMed |
| Identification of Candidate lncRNA and Pseudogene Biomarkers Associated with Carbon-Nanotube-Induced Malignant Transformation of Lung Cells and Prediction of Potential Preventive Drugs. | Int J Environ Res Public Health | 2022 | 35270630 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. | Cells | 2022 | 35269424 | PubTator, text mining | PubMed |
| Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations. | Molecules | 2022 | 35268688 | PubTator, text mining | PubMed |
| Structurally defined tandem-responsive nanoassemblies composed of dipeptide-based photosensitive derivatives and hypoxia-activated camptothecin prodrugs against primary and metastatic breast tumors. | Acta Pharm Sin B | 2022 | 35256957 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. | Elife | 2022 | 35256050 | PubTator, text mining | PubMed |
| Single cell analysis of mechanical properties and EMT-related gene expression profiles in cancer fingers. | iScience | 2022 | 35252814 | PubTator, text mining | PubMed |
| iApp: An Autonomous Inspection, Auscultation, Percussion, and Palpation Platform. | Front Physiol | 2022 | 35237180 | PubTator, text mining | PubMed |
| 8-oxodG accumulation within super-enhancers marks fragile CTCF-mediated chromatin loops. | Nucleic Acids Res | 2022 | 35234932 | PubTator, text mining | PubMed |
| DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells. | Mol Ther Nucleic Acids | 2022 | 35228897 | PubTator, text mining | PubMed |
| Human topoisomerases and their roles in genome stability and organization. | Nat Rev Mol Cell Biol | 2022 | 35228717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=56